IL77101A - Method for purifying a human tnf produced by recombinant dna technique - Google Patents
Method for purifying a human tnf produced by recombinant dna techniqueInfo
- Publication number
- IL77101A IL77101A IL77101A IL7710185A IL77101A IL 77101 A IL77101 A IL 77101A IL 77101 A IL77101 A IL 77101A IL 7710185 A IL7710185 A IL 7710185A IL 77101 A IL77101 A IL 77101A
- Authority
- IL
- Israel
- Prior art keywords
- recombinant dna
- dna technique
- purifying
- human tnf
- tnf produced
- Prior art date
Links
- 238000000034 method Methods 0.000 title abstract 3
- 108020004511 Recombinant DNA Proteins 0.000 title abstract 2
- 238000011725 BALB/c mouse Methods 0.000 abstract 1
- 206010039491 Sarcoma Diseases 0.000 abstract 1
- 239000013543 active substance Substances 0.000 abstract 1
- 239000011543 agarose gel Substances 0.000 abstract 1
- 239000007864 aqueous solution Substances 0.000 abstract 1
- 238000004440 column chromatography Methods 0.000 abstract 1
- 230000001472 cytotoxic effect Effects 0.000 abstract 1
- 230000002008 hemorrhagic effect Effects 0.000 abstract 1
- 230000001939 inductive effect Effects 0.000 abstract 1
- 230000017074 necrotic cell death Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/525—Tumour necrosis factor [TNF]
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S530/00—Chemistry: natural resins or derivatives; peptides or proteins; lignins or reaction products thereof
- Y10S530/827—Proteins from mammals or birds
- Y10S530/828—Cancer
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Molecular Biology (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- General Engineering & Computer Science (AREA)
- Gastroenterology & Hepatology (AREA)
- Wood Science & Technology (AREA)
- Toxicology (AREA)
- Biomedical Technology (AREA)
- Biotechnology (AREA)
- Medicinal Chemistry (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Physics & Mathematics (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP59246184A JPS61124392A (ja) | 1984-11-22 | 1984-11-22 | 遺伝子組換体の産生する生理活性物質の精製法 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL77101A true IL77101A (en) | 1991-01-31 |
Family
ID=17144758
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL77101A IL77101A (en) | 1984-11-22 | 1985-11-19 | Method for purifying a human tnf produced by recombinant dna technique |
Country Status (11)
| Country | Link |
|---|---|
| US (1) | US4880915A (enExample) |
| EP (1) | EP0183198B1 (enExample) |
| JP (1) | JPS61124392A (enExample) |
| KR (1) | KR940000542B1 (enExample) |
| AT (1) | ATE50794T1 (enExample) |
| AU (1) | AU591879B2 (enExample) |
| CA (1) | CA1265650A (enExample) |
| DD (1) | DD240216A5 (enExample) |
| DE (1) | DE3576362D1 (enExample) |
| IL (1) | IL77101A (enExample) |
| SU (1) | SU1630602A3 (enExample) |
Families Citing this family (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP0155549B1 (en) * | 1984-03-06 | 1991-03-20 | Dainippon Pharmaceutical Co., Ltd. | Dna encoding human tumor necrosis factor and human tumor necrosis factor polypeptide |
| US5288852A (en) * | 1984-03-06 | 1994-02-22 | Dainippon Pharmaceutical Co., Ltd. | Human tumor necrosis factor polypeptides |
| US4879226A (en) * | 1984-04-06 | 1989-11-07 | Asahi Kasei Kogyo Kabushiki Kaisha | Novel human physiologically active polypeptide |
| US6686455B1 (en) * | 1984-07-05 | 2004-02-03 | Genentech, Inc. | Tumor necrosis factor |
| IL73883A (en) * | 1984-12-20 | 1990-12-23 | Yeda Res & Dev | Monoclonal antibodies against tnf-alpha,hybridomas producing them and method for the purification of tnf-alpha |
| AU601675B2 (en) * | 1984-12-21 | 1990-09-20 | Biogen, Inc. | Purification, production and use of tumor necrosis factors |
| JPS61155330A (ja) * | 1984-12-28 | 1986-07-15 | Denichi Mizuno | 蛋白質標品 |
| US4870163A (en) * | 1985-08-29 | 1989-09-26 | New York Blood Center, Inc. | Preparation of pure human tumor necrosis factor and hybridomas producing monoclonal antibodies to human tumor necrosis factor |
| US4777242A (en) * | 1986-10-10 | 1988-10-11 | Phillips Petroleum Company | Purification of recombinant tumor necrosis factor |
| US5391706A (en) * | 1987-07-16 | 1995-02-21 | Schering Plough Corporation | Purification of GM-CSF |
| EP0368904A1 (en) * | 1987-07-16 | 1990-05-23 | Schering Corporation | Purification of gm-csf |
| US5597485A (en) * | 1988-05-13 | 1997-01-28 | Vilmax S.A. | Process for separating proteins |
| DE4331358A1 (de) * | 1992-10-12 | 1994-04-14 | Braun Melsungen Ag | Verfahren zur quantitativen selektiven Entfernung oder präparativen Gewinnung von Tumor-Nekrose-Faktor (TNF) oder/und Lipopolysacchariden (LPS) aus wäßrigen Flüssigkeiten |
| DE19515554C2 (de) * | 1995-04-27 | 1999-06-17 | Braun Melsungen Ag | Verwendung eines Mittels und Vorrichtung zur simultanen extrakorporalen Elimination von Tumor-Nekrose-Faktor alpha und bakteriellen Lipopolysacchariden aus Vollblut oder/und Blutplasma |
| US6887377B2 (en) * | 2001-02-01 | 2005-05-03 | Sigma-Aldrich Co. | Affinity matrices with enhanced visibility for molecular pull-down and immunoprecipitation applications |
| CA2508375C (en) | 2002-12-02 | 2014-05-27 | Abgenix, Inc. | Antibodies directed to tumor necrosis factor and uses thereof |
| US20050287515A1 (en) * | 2004-06-24 | 2005-12-29 | Reinhold Deppisch | Removal of bacterial DNA from therapeutic fluid formulations |
| EP3430160A1 (en) | 2016-03-17 | 2019-01-23 | Delta Instruments B.V. | Detection of cells in a liquid sample |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4879226A (en) * | 1984-04-06 | 1989-11-07 | Asahi Kasei Kogyo Kabushiki Kaisha | Novel human physiologically active polypeptide |
| US4677064A (en) * | 1984-11-09 | 1987-06-30 | Cetus Corporation | Human tumor necrosis factor |
| US4677063A (en) * | 1985-05-02 | 1987-06-30 | Cetus Corporation | Human tumor necrosis factor |
| US4770995A (en) * | 1985-08-29 | 1988-09-13 | New York Blood Center, Inc | Detection of the sensitivity of cells to the effects of tumor necrosis factor and lymphotoxin |
| US4677197A (en) * | 1985-10-30 | 1987-06-30 | Cetus Corporation | Purification method for tumor necrosis factor |
-
1984
- 1984-11-22 JP JP59246184A patent/JPS61124392A/ja active Granted
-
1985
- 1985-11-19 IL IL77101A patent/IL77101A/xx not_active IP Right Cessation
- 1985-11-19 US US06/799,509 patent/US4880915A/en not_active Expired - Fee Related
- 1985-11-20 CA CA000495773A patent/CA1265650A/en not_active Expired - Lifetime
- 1985-11-21 DD DD85283097A patent/DD240216A5/de not_active IP Right Cessation
- 1985-11-21 DE DE8585114806T patent/DE3576362D1/de not_active Expired - Lifetime
- 1985-11-21 EP EP85114806A patent/EP0183198B1/en not_active Expired - Lifetime
- 1985-11-21 AT AT85114806T patent/ATE50794T1/de not_active IP Right Cessation
- 1985-11-21 AU AU50248/85A patent/AU591879B2/en not_active Ceased
- 1985-11-22 SU SU853985474A patent/SU1630602A3/ru active
- 1985-11-22 KR KR1019850008752A patent/KR940000542B1/ko not_active Expired - Fee Related
Also Published As
| Publication number | Publication date |
|---|---|
| SU1630602A3 (ru) | 1991-02-23 |
| KR940000542B1 (ko) | 1994-01-24 |
| EP0183198B1 (en) | 1990-03-07 |
| DE3576362D1 (de) | 1990-04-12 |
| US4880915A (en) | 1989-11-14 |
| KR860004149A (ko) | 1986-06-18 |
| EP0183198A1 (en) | 1986-06-04 |
| DD240216A5 (de) | 1986-10-22 |
| AU5024885A (en) | 1986-05-29 |
| JPH0229317B2 (enExample) | 1990-06-28 |
| JPS61124392A (ja) | 1986-06-12 |
| CA1265650A (en) | 1990-02-06 |
| ATE50794T1 (de) | 1990-03-15 |
| AU591879B2 (en) | 1989-12-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL77101A (en) | Method for purifying a human tnf produced by recombinant dna technique | |
| ES8501635A1 (es) | Un procedimiento de fraccionamiento de plasma sanguineo | |
| IT1232827B (it) | Proteine biologicamente attive, formulazioni che le contengono e metodo per prepararle ed applicarle | |
| MY103892A (en) | Interleukin-2 of high purity production and use | |
| ATE140968T1 (de) | Kultur des wachstumsfaktors der vaskularen endothelialzellen und dns, die dafür kodiert | |
| IT8119838A0 (it) | Sostanze di supporto per immobilizzare sostanze bio-attive ed adsorbenti selettivi,elettrodi selettivi e colonne per analisi in cui si impiegano dette sostanze di supporto | |
| DE3566613D1 (en) | Medical treatment apparatus for applying sparks to the skin from bipolar electrodes | |
| LU90806I2 (fr) | Ovidrelle-choriogonadotropine alfa et ses d-riv-s pharmaceutiquement acceptables | |
| AU571372B2 (en) | Gel based delivery of active substances | |
| DK16890A (da) | Antiviral eller antibakteriel forbindelse og frem gangsmaade til anvendelse heraf | |
| IL72985A0 (en) | Homogenous immune interferon fragment,its manufacture and pharmaceutical compositions containing it | |
| ES2000030A6 (es) | Metodo de purificar factor sanguineo viii:c | |
| FR2522324B1 (fr) | Pyrrole-acetamides, leur procede de preparation et composition therapeutique les contenant | |
| EP0137543A3 (en) | Pharmaceutical composition for the therapy of peripheral arteriopathies | |
| NZ224295A (en) | A method of producing native or physiologically active secondary structure in physiologically inactive proteins | |
| FR2611205B1 (fr) | Dipeptides, procede de preparation et utilisation dans le dosage de proteases | |
| FI891712A7 (fi) | Terapeuttisesti vaikuttavia syklometyleeni-1,2-bikarboksyylihappojen amiineja, menetelmiä niiden valmistamiseksi sekä niitä sisältäviä farmaseuttisia koostumuksia | |
| DE3460575D1 (en) | Process to improve the activity of high molecular crosslinked polycarbonacids | |
| IT1179899B (it) | Procedimento per la selezione di cellule in grado di secernere una sostanza specifica da una coltura di cellule | |
| GB2126920B (en) | Liquid active substance-containing membrane and process for its production | |
| MY103539A (en) | Purification of gm-csf | |
| IT1173502B (it) | Procedimento per la purificazione di soluzioni contenenti fruttosio 2-6 difosfato (f-2,6-p2) e utilizzazione del composto cosi' ottenuto in terapia | |
| OA08355A (fr) | Nouveaux benzamides, leur procédé de préparation et leur application dans le domaine thérapeutique. | |
| FR2527630B1 (fr) | Enzyme leucocytaire humaine de type pepsique, procede pour sa preparation et agent therapeutique la contenant | |
| AU6560886A (en) | DNA sequence containing the DNA sequence coding for human tissue plasminogen activator originating from human normal cells, recombinant DNA incorporating the DNA sequence, host cells transformed with the recombinant DNA, and process for producing human tissue plasminogen activator by use of the host cells |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RH | Patent void |